NO994309L - Fremgangsmaater for undertrykkelse av tumorvekst med kombinasjoner av isoprenoider og statiner - Google Patents

Fremgangsmaater for undertrykkelse av tumorvekst med kombinasjoner av isoprenoider og statiner

Info

Publication number
NO994309L
NO994309L NO994309A NO994309A NO994309L NO 994309 L NO994309 L NO 994309L NO 994309 A NO994309 A NO 994309A NO 994309 A NO994309 A NO 994309A NO 994309 L NO994309 L NO 994309L
Authority
NO
Norway
Prior art keywords
statins
tumor growth
isoprenoids
combinations
methods
Prior art date
Application number
NO994309A
Other languages
English (en)
Other versions
NO994309D0 (no
Inventor
Charles Elson
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of NO994309D0 publication Critical patent/NO994309D0/no
Publication of NO994309L publication Critical patent/NO994309L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

En fremgangsmåte for hemming av tumorvekst blir beskrevet. I en utførelsesform omfatter fremgangsmåten trinnet ved å eksponere tumorceller for en effektiv mengde av en sammensetning omfattende minst to forbindelser valgt blant gruppen omfattende tocotrienoler, statiner og iononer.
NO994309A 1997-03-04 1999-09-03 Fremgangsmaater for undertrykkelse av tumorvekst med kombinasjoner av isoprenoider og statiner NO994309L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3979097P 1997-03-04 1997-03-04
PCT/US1998/003470 WO1998038993A1 (en) 1997-03-04 1998-02-23 Method of suppressing tumor growth with combinations of isoprenoids and statins

Publications (2)

Publication Number Publication Date
NO994309D0 NO994309D0 (no) 1999-09-03
NO994309L true NO994309L (no) 1999-09-03

Family

ID=21907353

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994309A NO994309L (no) 1997-03-04 1999-09-03 Fremgangsmaater for undertrykkelse av tumorvekst med kombinasjoner av isoprenoider og statiner

Country Status (13)

Country Link
US (2) US6133312A (no)
EP (1) EP0986383A1 (no)
JP (1) JP2001507363A (no)
KR (1) KR20000075919A (no)
AU (1) AU729355B2 (no)
BR (1) BR9808157A (no)
CA (1) CA2283333A1 (no)
HU (1) HUP0002049A2 (no)
IL (1) IL131628A0 (no)
NO (1) NO994309L (no)
PL (1) PL335506A1 (no)
RU (1) RU2179440C2 (no)
WO (1) WO1998038993A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6239114B1 (en) * 1997-09-26 2001-05-29 Kgk Synergize Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols
US6251400B1 (en) * 1997-09-26 2001-06-26 Kgk Synergize Inc Compositions and methods of treatment of neoplastic diseases and hypercholesterolemia with citrus limonoids and flavonoids and tocotrienols
US6703384B2 (en) 1998-09-23 2004-03-09 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
EP1137427A1 (en) * 1998-12-07 2001-10-04 Ecosmart Technologies Inc. Cancer treatment composition and method using natural plant essential oils with signal transduction modulators
CN1243000C (zh) * 2000-02-11 2006-02-22 研究发展基金会 生育酚、生育三烯酚、其它苯并二氢吡喃和侧链衍生物,及其用途
US20030104090A1 (en) * 2000-05-05 2003-06-05 Levy Pedro E. Supplements containing annatto extracts and carotenoids and methods for using the same
US6566397B2 (en) * 2000-07-18 2003-05-20 Wisconsin Alumni Research Foundation Acyclic isoprenoid ether derivatives as chemotherapeutics
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
US7074825B2 (en) * 2002-03-07 2006-07-11 Huanbiao Mo Composition and method for treating cancer
CA2521149C (en) * 2003-04-08 2014-03-25 Barrie Tan Annatto extract compositions, including geranyl geraniols and methods of use
US7989006B2 (en) * 2003-04-08 2011-08-02 American River Nutrition, Inc. Annatto extract compositions, including geranyl geraniols and methods of use
US20050037102A1 (en) * 2003-07-18 2005-02-17 Barrie Tan Annatto extract compositions including tocotrienols and tocopherols and methods of use
CN1938012A (zh) * 2004-03-31 2007-03-28 兴和株式会社 外用剂
KR20070088325A (ko) * 2004-05-26 2007-08-29 케이지케이 시너자이즈 인코포레이티드 플라보노이드 및 토코트리에놀을 포함하는 조성물 및그에따른 방법
DE102006008074B4 (de) * 2006-02-22 2013-08-14 RUHR-UNIVERSITäT BOCHUM Behandlung von Krebs mit Geruchsrezeptor-Liganden
US8288369B2 (en) * 2006-06-27 2012-10-16 University Of South Florida Delta-tocotrienol treatment and prevention of pancreatic cancer
US20090004290A1 (en) * 2007-06-30 2009-01-01 Voelker Kirk G Red yeast rice compound for cancer chemoprevention
WO2010124223A1 (en) * 2009-04-23 2010-10-28 First Tech International Limited Anti-cancer tocotrienol analogues and associated methods
US9180113B2 (en) * 2009-09-01 2015-11-10 First Tech International Limited Tocotrienol compositions
WO2011097481A1 (en) * 2010-02-05 2011-08-11 First Tech International Limited Tocotrienol esters
US20130158106A1 (en) 2010-06-02 2013-06-20 The United States Of America As Represented By The Department Of Veteran Affairs Tocopherol derivatives and methods of use
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose
KR20160068776A (ko) 2013-09-13 2016-06-15 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 방사선 효과의 완화 및 예방을 위한 조성물의 제조 및 용도
US20160324914A1 (en) 2015-05-05 2016-11-10 Tocol Pharmaceuticals, Llc Use of rice bran oil distillate extract for prevention and mitigation of the effects of radiation

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34617A (en) * 1862-03-04 Improved cylinder for grain scouring and thrashing machines
US33885A (en) * 1861-12-10 Improvement
USRE33885E (en) 1975-11-03 1992-04-14 The Procter & Gamble Company Compositions for inhibiting absorption of cholesterol
US4005196A (en) 1976-02-12 1977-01-25 The Procter & Gamble Company Vitaminized compositions for treating hypercholesterolemia
US4789554A (en) * 1985-12-05 1988-12-06 The Procter & Gamble Company High temperature vacuum steam distillation process to purify and increase the frylife of edible oils
JPH029875A (ja) * 1988-03-16 1990-01-12 Bio Ind Kyokai トコフェロール及びトコトリエノールの製造方法
DE3903991A1 (de) * 1989-02-10 1990-08-30 Basf Ag Phenylhydrazone des (beta)-jonons, ihre herstellung und daraus hergestellte arzneimittel und kosmetika
US5217992A (en) * 1989-10-04 1993-06-08 Bristol-Myers Squibb Company Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders
US5554647A (en) * 1989-10-12 1996-09-10 Perricone; Nicholas V. Method and compositions for treatment and/or prevention of skin damage and aging
US5574063A (en) * 1989-10-12 1996-11-12 Perricone; Nicholas V. Method and compositions for topical application of ascorbic acid fatty acid esters for treatment and/or prevention of skin damage
US5157132A (en) * 1990-05-18 1992-10-20 Carotech Associates Integrated process for recovery of carotenoids and tocotrienols from oil
US5393776A (en) * 1990-09-14 1995-02-28 Bristol-Myers Squibb Company Tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
US5204373A (en) * 1991-08-26 1993-04-20 Bristol-Myers Squibb Company Farnesylated tetrahydro-naphthalenols as hypolipidemic agents
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
CA2124086A1 (en) * 1991-11-22 1993-05-27 Ronald H. Lane Tocotrienols and tocotrienol-like compounds and methods for their use
AU4275793A (en) * 1992-02-25 1993-09-13 Warner-Lambert Company Cytoprotective compositions containing pyruvate and antioxidants
IL104736A0 (en) * 1992-03-27 1993-06-10 Zeagen Inc Method for producing beta-carotene using a fungal mated culture
PT642341E (pt) * 1992-05-13 2001-01-31 Us Health Utilizacao de inibidores de redutase de 3-hidroxi-3-metilglutaril coenzima a no tratamento de cancro
US5376361A (en) * 1993-01-13 1994-12-27 Perricone; Nicholas V. Method and compositions for topical application to the skin for prevention and/or treatment of radiation-induced skin damage
US5411969A (en) * 1993-04-16 1995-05-02 Bristol-Myers Squibb Company Antihyperlipidemic/antioxidant dihydroquinolines
US5391765A (en) * 1993-04-16 1995-02-21 Bristol-Myers Squibb Company Cholesterol lowering/antioxidant nitroxides
US5475029A (en) * 1993-07-08 1995-12-12 The Board Of Trustees Of The Leland Stanford Junior University Farnesyl compounds as cholesterol lowering agents
US5500154A (en) * 1994-10-20 1996-03-19 The Procter & Gamble Company Detergent compositions containing enduring perfume

Also Published As

Publication number Publication date
NO994309D0 (no) 1999-09-03
EP0986383A1 (en) 2000-03-22
WO1998038993A1 (en) 1998-09-11
CA2283333A1 (en) 1998-09-11
KR20000075919A (ko) 2000-12-26
IL131628A0 (en) 2001-01-28
PL335506A1 (en) 2000-04-25
RU2179440C2 (ru) 2002-02-20
AU729355B2 (en) 2001-02-01
HUP0002049A2 (hu) 2000-10-28
US6133312A (en) 2000-10-17
US6441029B1 (en) 2002-08-27
BR9808157A (pt) 2000-03-28
AU6335198A (en) 1998-09-22
JP2001507363A (ja) 2001-06-05

Similar Documents

Publication Publication Date Title
TR199801361T2 (xx) Yeni ikameli imidazol bile�imleri.
TR199902516T2 (xx) Kalsilitik bile�imleri.
TR199801360T2 (xx) Yeni ikameli imidazol bile�imleri.
EP0935415A4 (en) METHOD FOR MAKING CONNECTIONS INTO A CELL
NO975716D0 (no) Imidazolforbindelser
EP1045851A4 (en) SUBSTITUTED PORPHYRINS
AU7585598A (en) Raf kinase inhibitors
FI971262L (fi) Tehostajat, kuten asetosyringoni
AU1296099A (en) Methods and compositions for treating dermatoses
DK125796A (da) I form af små molekyler foreliggende inhibitorer for rotamaseaktivitet
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
AU8693098A (en) Compositions and methods for treating diabetes
BR9808157A (pt) Processo de inibição do desenvolvimento de células tumorais e de tumor e composição farmacêutica
EP1009755A4 (en) STEROID SULFATASE INHIBITORS AND METHODS OF PRODUCING AND USING THE SAME
NO995267L (no) Leptin som en inhibitor av tumorcelleproliferering
AU3401199A (en) Method and composition for treating psoriasis
GB2324091B (en) Metalloproteinase inhibitors
DE69736945D1 (de) Biphenylverbindungen sowie ihre anwendung als östrogene mittel
TR199901386T2 (en) �midazopiridazinler.
AU6645398A (en) Method for protecting bytecode
ES2185196T3 (es) Un procedimiento para la preparacion de tetraazamacrociclos.
AU4672597A (en) Method for treating urinary reflux
NO912782D0 (no) Fremgangsmaate for behandling av skrap av legeringer av sjeldne jordmetaller/overgangsmetaller.
BR9100315A (pt) Composto,composicao lubrificante,metodo de estabilizacao de lubrificantes
CA2193849A1 (en) Method for treating anxiety

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application